Market Cap

Cantargia AB Market Capitalization:

kr779.9 Million

SEK as of July 1, 2024

US$73.5 Million

business Cantargia AB Company Profile

Cantargia AB Main Stock Listing

OMX: CANTA

Market Capitalization History of Cantargia AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Cantargia AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr686.6 M -44.06%
Jan. 1, 2023 kr1.23 B -55.34%
Jan. 1, 2022 kr2.75 B -69.35%
Jan. 1, 2021 kr8.97 B 155.86%
Jan. 1, 2020 kr3.50 B 45.57%
Jan. 1, 2019 kr2.41 B 96.02%
Jan. 1, 2018 kr1.23 B 21.31%
Jan. 1, 2017 kr1.01 B -39.58%
Jan. 1, 2016 kr1.68 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Cantargia AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Cantargia AB has the following listings and related stock indices.


Stock: OMX: CANTA

Stock: FSX: 7V3

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.